ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,095.57
0.13%
Dow Jones
43,408.47
0.32%
Gold vs US Dollar
2,668.79
0.62%
Brent Oil
73.63
1.08%
Bitcoin
98,340.74
4.22%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) News

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
20/11/202416:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
19/11/202415:47Alliance NewsAlliance NewsAstraZeneca "disappointed" as breast cancer drug blocked for NHS useLSE:AZNAstrazeneca Plc
19/11/202415:47Alliance NewsAlliance NewsAstraZeneca "disappointed" as breast cancer drug blocked for NHS useLSE:AZNAstrazeneca Plc
18/11/202412:43Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca chair and CAB Payments director buyLSE:AZNAstrazeneca Plc
18/11/202412:43Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca chair and CAB Payments director buyLSE:AZNAstrazeneca Plc
18/11/202409:01Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails recommended EU approval of TagrissoLSE:AZNAstrazeneca Plc
18/11/202409:01Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails recommended EU approval of TagrissoLSE:AZNAstrazeneca Plc
18/11/202407:00RNS Regulatory NewsAstraZeneca PLC Tagrisso recommended for EU approval - LAURALSE:AZNAstrazeneca Plc
15/11/202414:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
15/11/202411:04Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca CEO Soriot buys GBP2 million in sharesLSE:AZNAstrazeneca Plc
15/11/202411:04Alliance NewsAlliance NewsDIRECTOR DEALINGS: AstraZeneca CEO Soriot buys GBP2 million in sharesLSE:AZNAstrazeneca Plc
15/11/202410:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
13/11/202416:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
12/11/202419:50Alliance NewsAlliance NewsIN BRIEF: Merck trial shows Koselugo effective in treating adultsLSE:AZNAstrazeneca Plc
12/11/202419:50Alliance NewsAlliance NewsIN BRIEF: Merck trial shows Koselugo effective in treating adultsLSE:AZNAstrazeneca Plc
12/11/202412:21Alliance NewsAlliance NewsEXTRA: AstraZeneca results impress but China a likely short-term dragLSE:AZNAstrazeneca Plc
12/11/202412:21Alliance NewsAlliance NewsEXTRA: AstraZeneca results impress but China a likely short-term dragLSE:AZNAstrazeneca Plc
12/11/202408:59Alliance NewsAlliance NewsTOP NEWS: AstraZeneca lifts annual guidance despite possible forex hitLSE:AZNAstrazeneca Plc
12/11/202408:59Alliance NewsAlliance NewsTOP NEWS: AstraZeneca lifts annual guidance despite possible forex hitLSE:AZNAstrazeneca Plc
12/11/202407:10RNS Regulatory NewsAstraZeneca PLC AstraZeneca invests $3.5 billion in USLSE:AZNAstrazeneca Plc
12/11/202407:05RNS Regulatory NewsAstraZeneca PLC KOMET Phase III trial met primary endpointLSE:AZNAstrazeneca Plc
12/11/202407:00RNS Regulatory NewsAstraZeneca PLC 9M and Q3 2024 ResultsLSE:AZNAstrazeneca Plc
12/11/202407:00RNS Regulatory NewsAstraZeneca PLC Dato-DXd new BLA submitted, NSQ BLA withdrawnLSE:AZNAstrazeneca Plc
08/11/202409:13Alliance NewsAlliance NewsAstraZeneca touts positive results from nasal polyp treatment studyLSE:AZNAstrazeneca Plc
08/11/202409:13Alliance NewsAlliance NewsAstraZeneca touts positive results from nasal polyp treatment studyLSE:AZNAstrazeneca Plc
08/11/202407:00RNS Regulatory NewsAstraZeneca PLC Tezspire nasal polyps trial met primary endpointsLSE:AZNAstrazeneca Plc
07/11/202411:14Alliance NewsAlliance NewsTOP NEWS: AstraZeneca says China chief detained as under investigationLSE:AZNAstrazeneca Plc
07/11/202411:14Alliance NewsAlliance NewsTOP NEWS: AstraZeneca says China chief detained as under investigationLSE:AZNAstrazeneca Plc
05/11/202418:39Alliance NewsAlliance NewsTOP NEWS: AstraZeneca pledges to assist in China probe as shares slideLSE:AZNAstrazeneca Plc
05/11/202418:39Alliance NewsAlliance NewsTOP NEWS: AstraZeneca pledges to assist in China probe as shares slideLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Your Recent History

LSE
POS
Plexus
LSE
VAST
Vast Resources
LSE
MIN
Minoan
LSE
STX
Shield Therapeutics
LSE
LIO
Liontrust Asset Management
LSE
POLX
Polarean Imaging
LSE
SYME
Supply@me Capital
LSE
LLOY
Lloyds Banking
LSE
GGP
Greatland Gold
LSE
TERN
Tern
LSE
JD.
Jd Sports Fashion
LSE
NEXN
Nexxen
LSE
NFDS
Northern Foods
LSE
AAZ
Anglo Asian Mining
LSE
NESF
Nextenergy Solar
LSE
ITM
Itm Power
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06